Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 18Liver Neoplasms 3Recurrence 2Uveal Melanoma 1Sarcoma 1Recurrence Hepatocellular Carcinoma 1Pleural Neoplasms 1Pancreatic Adenocarcinoma 1Neoplastic Cells, Circulating 1Neoplasm Recurrence, Local 1Mediastinal Neoplasms 1Malignant Neoplasm in the Head and Neck 1Lung Neoplasms 1Lung Metastases 1Liver Cirrhosis 1HCC 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Gemcitabine 11Albumin-Bound Paclitaxel 7Taxes 5130-nm albumin-bound paclitaxel 4Radiotherapy, Intensity-Modulated 3Radiotherapy 3Fluorouracil 3dehydroftorafur 2Oxaliplatin 2Losartan 2Leucovorin 2Irinotecan 2Cisplatin 2niraparib 1irinotecan sucrosofate 1folfirinox 1durvalumab 1X-Rays 1Surgical Procedures, Operative 1Standard of Care 1Specimen Handling 1S 1 (combination) 1Resistance Training 1Radiotherapy, Image-Guided 1Radiosurgery 1Radiation 1Panitumumab 1Pancreaticoduodenectomy 1Optical Imaging 1Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Pancreatic Adenocarcinoma × Ethiodized Oil × Clear all
NCT03865563 2020-01-27

Selective Transvenous Chemoembolization of Primary Pancreatic Tumors

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1 Withdrawn
Gastrointestinal

Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡